A 12.9 per cent increase in revenue to £81million and 20.2 per cent jump in adjusted earnings to £11.3million had left it comfortably ahead of market expectations, Microlise said.
Kromek separately published interim figures showing revenue of £3.7million, against £7.1million a year earlier, as its margin widened from 54.2 per cent to 56.9 per cent.
SMALL CAP MOVERS: Kromek eyes profitability after £30m Siemens Healthineers deal Kromek Group left investors cheering this week as it unmasked a road to profitability via a deal with Siemens Healthineers.
Shares in the radiation and bio-detection specialist rocketed almost 38 per cent, fuelled by Thursday's news of the $37.5million (£30.2million) cash deal with the German medical technology giant.
Molson Coors would also buy an 8.5 per cent stake in Fevertree for £71million under the agreement, which the latter said would be used for a share buyback.
